391 related articles for article (PubMed ID: 22103762)
41. [ACCOMPLISH and the risks with company sponsored clinical trials].
Furberg C
Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
[No Abstract] [Full Text] [Related]
42. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
Campbell MJ
Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
[No Abstract] [Full Text] [Related]
43. Economic efficiency of countries' clinical review processes and competitiveness on the market of human experimentation.
Ippoliti R
Value Health; 2013; 16(1):148-54. PubMed ID: 23337226
[TBL] [Abstract][Full Text] [Related]
44. Money in biomedicine: The senator's sleuth.
Wadman M
Nature; 2009 Sep; 461(7262):330-4. PubMed ID: 19759593
[No Abstract] [Full Text] [Related]
45. Note from the editor.
Freedman R
Am J Psychiatry; 2010 Nov; 167(11):1407. PubMed ID: 21041255
[No Abstract] [Full Text] [Related]
46. Medicine and the pharmaceutical industry.
Baxter P
Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
[No Abstract] [Full Text] [Related]
47. Health activists attack Indian compensation formula for deaths attributed to clinical trials.
Mudur G
BMJ; 2013 Oct; 347():f6295. PubMed ID: 24136639
[No Abstract] [Full Text] [Related]
48. Minimizing bias in industry-sponsored outcomes research.
Freeman RA
Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
[TBL] [Abstract][Full Text] [Related]
49. America's other drug problem: how the drug industry distorts medicine and politics.
Relman AS; Angell M
New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
[No Abstract] [Full Text] [Related]
50. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
James JS
AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
[TBL] [Abstract][Full Text] [Related]
51. Industry money skews drug overviews.
Giles J
Nature; 2005 Sep; 437(7058):458-9. PubMed ID: 16177748
[No Abstract] [Full Text] [Related]
52. Better regulation of industry-sponsored clinical trials is long overdue.
Wynia M; Boren D
J Law Med Ethics; 2009; 37(3):410-9, 395. PubMed ID: 19723252
[TBL] [Abstract][Full Text] [Related]
53. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? No.
Lawton V
BMJ; 2009 Nov; 339():b4953. PubMed ID: 19946144
[No Abstract] [Full Text] [Related]
54. Evaluating solutions to sponsorship bias.
Doucet M; Sismondo S
J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
[TBL] [Abstract][Full Text] [Related]
55. Data availability for industry sponsored trials: what should medical journals require?
Steinbrook R; Kassirer JP
BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
[No Abstract] [Full Text] [Related]
56. Why did Jesse die?
Walters J
Update; 2001 Nov; 17(2):E1. PubMed ID: 16130258
[No Abstract] [Full Text] [Related]
57. Industry and medicine: conflicting interests and the power of money.
Popovsky MA; Garcia N
Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
[No Abstract] [Full Text] [Related]
58. Industry sponsorship and authorship of clinical trials over 20 years.
Buchkowsky SS; Jewesson PJ
Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
[TBL] [Abstract][Full Text] [Related]
59. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
Newcombe JP; Kerridge IH
Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
[TBL] [Abstract][Full Text] [Related]
60. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
Babor TF
Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
